ShRNA-mediated gene silencing of AHR promotes the differentiation of P19 mouse embryonic carcinoma cells into cardiomyocytes

Introduction

The heart is the first organ to form in vertebrate embryogenesis (1). In vertebrates, the survival of the developing embryo depends on the heart and the circulatory systems, therefore cardiac abnormalities not only cause miscarriage and stillbirth, but also seriously affect the quality of life after birth (2). The heart is extremely sensitive to embryonic environmental changes during development. Certain physical, chemical and biological contaminants are known to contribute to cardiovascular disease (3,4). The current study shows that exposure to persistent organic pollutants, such as polychlorinated biphenyls (PCBs), is significantly correlated with heart disease (5,6). In China, PCB contamination has become a serious environmental problem. For example, in Jiangsu Province the concentration of PCBs in some surface water has exceeded the standard (20 ng/l) for the ‘Environmental Quality Standard for Surface Water’ (7). Total PCB concentration in human adipose tissue ranged from 4.1 to 125 ng/g lipid (mean 32.8 ng/g lipid), which significantly exceeds the mean total World Health Organization (WHO) toxicity equivalent (TEQ) values for PCBs in human adipose tissue, which is 16.2 pg/g lipid (8). Studies have also demonstrated that PCBs may pass through the placenta to the fetus in mothers who have been exposed before and during pregnancy (9,10).

The AHR belongs to the basic helix-loop-helix Per-Arnt-Sim family of transcriptional regulators. Several studies have shown that members of this family play key roles in a broad range of biological functions and that the biochemical and toxicological effects of PCBs act through the AHR pathway (11,12). However, little is known about the underlying effects of the AHR during the differentiation of embryonic carcinoma cell line P19 into cardiomyocytes.

In this study, we constructed two short hairpin (sh)RNA plasmid vectors against AHR that were capable of persistently generating small interfering (si)RNA in cells. We transfected these vectors into the P19 cells to determine the effects of AHR gene silencing on their differentiation. Furthermore, we examined the expression levels of four critical genes (ARNT, CYP1A1, GSK3β and β-catenin), and determined which are components of the AHR and Wnt signaling pathways using quantitative polymerase chain reaction (qPCR).

Materials and methods

Cell culture

P19 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured in α-minimal essential medium (α-MEM; Gibco-BRL, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; Gibco-BRL), 100 U/ml penicillin and 100 μg/ml streptomycin in bacteriological dishes in an atmosphere of 5% CO2 in air at 37°C. Embryoid bodies (EB) were transferred to 10-cm bacterial dishes that contained 15 ml α-MEM supplemented with 1% DMSO (Sigma, St. Louis, MO, USA), 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin to induce cardiac differentiation, and then cultured for 96 h. The EBs were then collected and transferred to 6-cm bacterial dishes supplemented with α-MEM containing 10% FBS for an additional 6 days. Cell morphological changes during the growth and differentiation of P19 were observed under an inverted microscope (Nikon, Tokyo, Japan).

Construction of shRNA expression vector for AHR

Two target DNA fragments were designed and constructed for AHR based on shRNA design, enzyme insertion sites in the pGPU6-GFP-Neo expression vector and the AHR exons (GenBank accession number: NM_013464.4) as cited in GenBank. The sequences of the primers used were: shRNA1 sense: 5′-CAGAGCGTATATGAGCTCATCCATA-3′; and antisense: 5′-GTCTCGCATATACTCGAGTAGGTAT-3′; shRNA2 sense: 5′-CCTCCACAGGCAGCAGTCTATTATA-3′; and antisense: 5′-GGAGGTGTCCGTCGTCAGATAATAT-3′. Another unrelated sequence was used as the control. No homologous sequence was found by BLAST analysis. Loop-stem structure was a non-homologous base (TTCAAGAGA), which was non-complementary to AHR. Enzyme insertion sites for BbsI and BamHI were constructed into the ends of the oligonucleotide fragments, and the specificity of constructed oligonucleotides strands was analyzed by the BLAST program. The primer sequences were as follows: shRNA1 sense: 5′-CACCGCAGAGCGTATATGAGCTCATCCATATTCAAG AGATATGGATGAGCTCATATACGCTCTGTTTTTTG-3′; and antisense: 5′-GATCCAAAAAACAGAGCGTATATGAGCTCATCCATATCTCTTGATATGGATGAGCTCATATACGCTCTGC-3′; shRNA2 sense: 5′-CACCGCCTCCACAGGCAGCAGTCTATTATATTCAAGAGATATAATAGACTGCTGCCTGTGGAGGTTTTTTG-3′; and antisense: 5′-GATCCAAAAAACCTCCACAGGCAGCAGTCTATTATATCTCTTGAATATAATAGACTGCTGCCTGTGGAGGC-3′. Sense and antisense oligonucleotides were annealed to generate a double-stranded oligonucleotide, and the annealed shRNA oligonucleotide fragment template was inserted into the pGPU6-GFP-Neo vector using T4 DNA ligase. The recombinant plasmid was then transformed into competent bacillus Escherichia coli, and the bacteria were cultured overnight in LB medium that contained kanamycin. Recombinant plasmids were extracted, purified and cut using restriction enzymes BbsI, BamHI and PstI in order to identify the correct fragments.

Plasmid transfection

P19 cells were digested with trypsin and seeded into 6-well plates. When the density of the cells on the slide reached 80–90% confluence they were transfected in four groups: the first group was the blank control, the second was the negative control, the third was the shRNA1 group and the fourth was the shRNA2 group. Transfection was performed in accordance with the manufacturer’s instructions. Briefly, P19 cells were seeded into 6-well plates at a density of 2.5×105 cells/well and cultured for 24 h. Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was mixed with Opti-MEM I medium, shRNA expression vectors were added to the solution and the cells were incubated at room temperature for 20–25 min. The transfection mixture was added to each well with 600 μl FBS-free α-MEM medium. The cells were incubated at 37°C for 4–6 h, and the medium was changed. α-MEM medium (1.5 ml) containing 10% FBS was added and the cells were incubated for another 24 h.

RNA and real-time qPCR

Total RNA was extracted from cells using TRIzol reagent according to the manufacturer’s instructions (Invitrogen). Total RNA (1 μg) was transcribed to cDNA using M-MLV reverse transcriptase. Real-time qPCR reactions were carried out using an MX3000 real-time instrument (Stratagene, Cedar Creek, TX, USA). Each PCR amplification was performed in triplicate, using the following conditions: samples were incubated at 95°C for 3 min for initial denaturation, and then subjected to 40 PCR cycles. Each PCR cycle consisted of 95°C for 30 sec and 62°C for 40 sec. Additionally, normalization to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was performed. The primer sequences used are listed in Table I.

Table I Primers used for real-time polymerase chain reaction (PCR).

Table I

Primers used for real-time polymerase chain reaction (PCR).

Gene name	Sequences (5′-3′)	Product length (bp)
AHR	F: ATGGAGAGGTGCTTCAGGTGCCG R: ATGGAGGGTGGCTGAAGTGGAGT	185
GATA4	F: CCTGCGGCCTCTACATGA R: AGGGTCTCACCAGCAGGA	136
Nkx2.5	F: CCTGCGGCCTCTACATGA R: AGGGTCTCACCAGCAGGA	222
ARNT	F: GACAGACCACAGGACAGTTCC R: AGCATGGACAGCATTTCTTGAA	172
CYP1A1	F: GGTTAACCATGACCGGGAACT R: TGCCCAAACCAAAGAGAGTGA	122
GSK3β	F: TGGCAGCAAGGTAACCACAG R: CGGTTCTTAAATCGCTTGTCCTG	189
β-catenin	F: ATGGAGCCGGACAGAAAAGC R: CTTGCCACTCAGGGAAGGA	108
GAPDH	F: TTCACCACCATGGAGAAGGC R: GGCATGGACTGTGGTCATGA	237

Statistical analysis

Values are shown as the mean ± standard deviation (SD). Statistical analyses were performed using one-way analysis of variance (ANOVA) and t-tests or Student’s-tests with a correction for multiple comparisons. P<0.05 was considered to indicate a statistically significant result.

Results

Identification of enzyme digestion

AHR-targeted shRNA expression vectors were cut using PstI. A DNA band of 5,180 bp was able to be digested, which indicated that the target gene segment AHR had been inserted into pGPU6-GFP-Neo vector (Fig. 1).

Figure 1 Restrictive enzyme incision analysis for pGPU6-GFP-Neo-AHR shRNA plasmid using RT-PCR. Lanes 1–5, pGPU6-GFP-Neo-AHR shRNA1 plasmid was cut off by PstI. Lanes 6–10, pGPU6-GFP-Neo-AHR shRNA2 plasmid was cut off by PstI. Lanes 11–15, pGPU6-GFP-Neo-AHR shRNA1 plasmid was cut off by BamHI. Lanes 16–20, pGPU6-GFP-Neo-AHR shRNA2 plasmid was cut off by BamHI. M, DNA marker.

Observation of transfection results

Transfection was carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. After 48 h, green fluorescence was observed in transfected cells under the fluorescence microscope, and the transfection rate was found to be approximately 50% (Fig. 2).

Figure 2 The expression of GFP (green fluorescent protein) in P19 cells transfected with pGPU6-GFP-Neo-AHR shRNA plasmids under a fluorescent microscope. (A) P19 cells transfected with pGPU6-GFP-Neo-AHR shRNA1 plasmids for 48 h. (B) P19 cells transfected with pGPU6-GFP-Neo-AHR shRNA2 plasmids for 48 h.

shRNA targeting AHR inhibited AHR mRNA expression in P19 cells

We used real-time qPCR to confirm the efficiency of shRNA silencing on AHR expression. No statistically significant difference was found in AHR mRNA expression between the mock treatment group and the blank control group. Moreover, the two shRNA groups showed varying degrees of inhibitory effect (Fig. 3). Therefore, the AHR-targeted shRNA expression vectors were selected for subsequent experiments.

Figure 3 Effect of shRNA expression vectors on AHR mRNA expression in P19 cells. AHR mRNA inhibition rate for shRNA1 and shRNA2 was 64 and 52%, respectively, compared with the control group (*p<0.05).

Expression of marker gene during P19 cell differentiation

The GATA4 and Nkx2.5 genes are expressed in cardiomyocytes as cardiac-specific genes; therefore, their expression was examined during P19 cell differentiation. GATA4 and Nkx2.5 gene expression levels were upregulated during heart development (from day 0 to day 10) and the expression levels were increased on day 10 in the AHR-silenced P19 cells compared with the control cells (Fig. 4).

Figure 4 Expression of GATA4 and Nkx2.5 during P19 cell differentiation by real-time quantitative PCR (qPCR). (A and B) No difference in the expression levels of GATA4 and Nkx2.5 genes was found between AHR-silencing P19 cells and the controls on day 0. On day 10, GATA4 and Nkx2.5 expression levels were markedly higher in the AHR-silencing P19 cells than in the controls. Data resulted from three independent experiments (**p<0.01).

Expression of AHR and Wnt signal transduction genes during P19 cell differentiation

We detected the expression levels of AHR signal transduction-related genes, including ARNT and CYP1A, using qPCR. On day 10 expression levels of ARNT and CYP1A1 were lower in the AHR-silenced P19 cells than in the controls (Fig. 5). We also determined the expression levels of genes GSK3β and β-catenin involved in the Wnt signal transduction pathway. Results from qPCR revealed that β-catenin was suppressed, whereas GSK3β was increased, in the AHR-silenced P19 cells (Fig. 6).

Figure 5 Expression of Wnt signal transduction genes, GSK3β and β-catenin, during P19 cell differentiation by real-time quantitative PCR (qPCR). GSK3β gene expression was higher in the AHR-silencing P19 cells than in the controls (days 0 and 10) (A). No difference in expression levels of the β-catenin gene was found between AHR-silencing P19 cells and the controls on day 0. On day 10, β-catenin expression was much lower in the AHR-silencing P19 cells than in the controls. Data are from three independent experiments (*p<0.05).

Figure 6 Expression of AHR signal transduction genes during P19 cell differentiation by real-time quantitative PCR (qPCR). No difference in expression levels of ARNT gene was found between AHR-silencing P19 cells and the controls on day 0. On day 10, ARNT was markedly lower in the AHR-silencing P19 cells than in the controls (A). CYP1A1 was much lower in the AHR-silencing P19 cells than in the controls (days 0 and 10). Data are from three independent experiments (*p<0.05, **p<0.01).

Discussion

RNA interference (RNAi) is one of the most powerful technologies for the specific blocking of gene expression (13). In this study, we successfully transfected two shRNAs that targeted the AHR gene into P19 cells. The results showed that AHR mRNA expression examined in the shRNA1 and shRNA2 groups was inhibited by approximately 64 and 52%, respectively, compared with the control group.

Using shRNA, we found that the gene silencing of AHR caused the expression levels of two myocardial cell differentiation-related genes (GATA4 and Nkx2.5) to be elevated. In addition, real-time qPCR revealed that the expression of ARNT, CYP1A1 and β-catenin was suppressed, but the expression of GSK3β was increased in the AHR-silenced P19 cells. These results suggest that the silencing effect of AHR promotes the differentiation of P19 mouse embryonic carcinoma cells into cardiomyocytes. The Wnt signal transduction pathway may be responsible for the effect of silencing AHR in P19 cells.

Findings of studies have shown that PCBs are one of the most ubiquitous contaminants that are important in the development of cardiovascular disease (14,15). It is generally believed that the effects of PCBs are mediated through the AHR pathway (16). Lund et al found that knockout of the AHR gene in mice disrupted cardiovascular homeostasis, which caused significant cardiac hypertrophy and elevated levels of expression of cardiovascular markers (17). In this study, we also found that the expression of cardiac development-specific genes was induced in the AHR-silenced P19 cells. These results suggested that the AHR signaling pathway is crucial in cardiovascular development programs.

Wnt protein and its signaling pathways are among the most intensely studied pathways in biology (18). Previous studies have suggested that the Wnt proteins are capable of inducing cell proliferation, differentiation and maturation (19). The canonical Wnt signaling pathway may be manipulated to regulate the expansion and differentiation of cardiac progenitor cells, and Wnt signaling was found to be essential to the development of the heart in mammals (20,21). In this study, the expression of the critical AHR signaling pathway genes (AHR, ARNT and CYP1A1) was reduced in the AHR-silenced P19 cells. In addition, the β-catenin expression level was decreased but GSK3β was increased in the AHR-silenced P19 cells during heart development. Taking into account the fact that AHR activation may inappropriately activate the Wnt signaling pathway and that there is crosstalk between AHR and Wnt signaling (22), we suggest that the silencing of AHR inhibited the differentiation of embryonic carcinoma P19 cells, possibly through the Wnt signaling transduction pathway.

In conclusion, we constructed a shRNA expression vector for AHR. Findings of the present study showed that the expression levels of GATA4 and Nkx2.5 genes were increased in the AHR-silenced P19 cells. We also found that ARNT, CYP1A1 and β-catenin were suppressed, whereas GSK3β was elevated, in the AHR-silenced P19 cells. However, the exact mechanisms of how the AHR and Wnt signaling pathways affect the differentiation of P19 cells into cardiac myocytes should be investigated.

Acknowledgements

This study was supported by a grant from the National Natural Science Foundation of China (no. 30973213).

References